Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9000828 | Research in Social and Administrative Pharmacy | 2005 | 21 Pages |
Abstract
Given the polarization observed within this survey, we examined how DTCA policy has evolved in Canada since 2001. The federal government has legislative authority over DTCA, but bears few of the additional costs potentially incurred through policy change. These fall to the provinces, which provide an eroding patchwork of public coverage for prescription drugs in the face of rapidly increasing costs. No new federal legislation has been tabled since 2001. However, considerable shifts in administrative policy have occurred, all supportive of expanded advertising. Thus, the law continues to be restrictive but its application less so.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Barbara Ph.D., Morris M.B.A., Ph.D., Joel M.D., Ken L. M.D., Ph.D.,